4.1 Article Proceedings Paper

NF1 mutations and molecular testing

Journal

JOURNAL OF CHILD NEUROLOGY
Volume 17, Issue 8, Pages 555-561

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/088307380201700803

Keywords

-

Funding

  1. NINDS NIH HHS [R29-NS31550] Funding Source: Medline

Ask authors/readers for more resources

Neurofibromatosis 1 is a progressive autosomal dominant condition caused by mutations in the NF1 gene on chromosome 17. The condition shows clinical variable expressivity, with varying features even between family members who share the same mutation. Furthermore, it is impossible to precisely predict the severity and course of the condition, a source of frustration for families and physicians. Neurofibromatosis 1 is also heterogeneous at the mutation level, with more than 300 independent mutations having been reported in this gene. The mutation data have accumulated slowly owing to the variability of the mutation types and the size and complexity of the gene. This is also reflected in the lack of a simple, inexpensive, highly accurate DNA-based test for neurofibromatosis 1 at present. This article reviews current NF1 mutation spectrum and testing, discussing and illustrating mutation., mechanisms and pathogenetic effects, as well as factors affecting DNA testing and interpretation/diagnosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available